Caxton Associates LP Simulations Plus, Inc. Transaction History

Caxton Associates LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$37.1 - $57.45 $260,145 - $402,839	-7,012 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$38.45 - $55.66 $269,611 - $390,287	7,012 New	7,012 $277,000
Q4 2020 Feb 16, 2021	SELL	$53.26 - $77.18 $270,347 - $391,765	-5,076 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$57.51 - $75.36 $291,920 - $382,527	5,076 New	5,076 $383,000
Q4 2019 Feb 14, 2020	SELL	$29.07 - $35.63 $724,308 - $887,757	-24,916 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$28.19 - $41.75 $253,456 - $375,374	8,991 Added 56.46%	24,916 $863,000
Q2 2019 Aug 14, 2019	BUY	$19.91 - $28.97 $317,066 - $461,347	15,925 New	15,925 $455,000

172

16.8M

2.6K

300

Ticker SLP
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 20,297,700
Market Cap $535M
Description
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

Stay updated on Caxton Associates LP with notifications on news.